Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 21 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 20, 2025 Filed Jun 23, 2025 20:18 UTC |
Scadden DavidDirector
|
Exercise / conversionCommon stock | 2,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000049 · wk-form4_1750709929.xml · nonDerivative · entry 1 Scadden David · CIK 0001707715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:20 UTC |
Owen Adams CatherineDirector
|
GrantStock options (right to buy) · Derivative | 15,768 | $0.00 Strike: $35.50 | $0.00 |
DisclosureSEC source: 0001439222-25-000051 · wk-form4_1750710009.xml · derivative · entry 3 Owen Adams Catherine · CIK 0001816838 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,768 Underlying: Common stock · 15,768 shares Expires 2035-06-18 F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:20 UTC |
Owen Adams CatherineDirector
|
GrantRestricted stock units · Derivative | 2,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000051 · wk-form4_1750710009.xml · derivative · entry 2 Owen Adams Catherine · CIK 0001816838 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,816 Underlying: Common stock · 2,816 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:27 UTC |
Ballal Rahul D.Director
|
GrantStock options (right to buy) · Derivative | 15,768 | $0.00 Strike: $35.50 | $0.00 |
DisclosureSEC source: 0001439222-25-000061 · wk-form4_1750710427.xml · derivative · entry 3 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,768 Underlying: Common stock · 15,768 shares Expires 2035-06-18 F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:27 UTC |
Ballal Rahul D.Director
|
GrantRestricted stock units · Derivative | 2,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000061 · wk-form4_1750710427.xml · derivative · entry 2 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,816 Underlying: Common stock · 2,816 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:25 UTC |
CAPELLO JEFFREY DDirector
|
GrantStock options (right to buy) · Derivative | 15,768 | $0.00 Strike: $35.50 | $0.00 |
DisclosureSEC source: 0001439222-25-000059 · wk-form4_1750710331.xml · derivative · entry 3 CAPELLO JEFFREY D · CIK 0001224108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,768 Underlying: Common stock · 15,768 shares Expires 2035-06-18 F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying this option vest as to 100% of the underlying shares on June 18, 2026. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:25 UTC |
CAPELLO JEFFREY DDirector
|
GrantRestricted stock units · Derivative | 2,861 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000059 · wk-form4_1750710331.xml · derivative · entry 2 CAPELLO JEFFREY D · CIK 0001224108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,861 Underlying: Common stock · 2,861 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:24 UTC |
Foster-Cheek Kaye IDirector
|
GrantStock options (right to buy) · Derivative | 15,768 | $0.00 Strike: $35.50 | $0.00 |
DisclosureSEC source: 0001439222-25-000057 · wk-form4_1750710263.xml · derivative · entry 4 Foster-Cheek Kaye I · CIK 0001312622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,768 Underlying: Common stock · 15,768 shares Expires 2035-06-18 F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:24 UTC |
Foster-Cheek Kaye IDirector
|
GrantRestricted stock units · Derivative | 2,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000057 · wk-form4_1750710263.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,816 Underlying: Common stock · 2,816 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:23 UTC |
FOUSE JACQUALYN ADirector
|
GrantStock options (right to buy) · Derivative | 15,768 | $0.00 Strike: $35.50 | $0.00 |
DisclosureSEC source: 0001439222-25-000055 · wk-form4_1750710197.xml · derivative · entry 3 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,768 Underlying: Common stock · 15,768 shares Expires 2035-06-18 F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:23 UTC |
FOUSE JACQUALYN ADirector
|
GrantRestricted stock units · Derivative | 2,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000055 · wk-form4_1750710197.xml · derivative · entry 2 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,816 Underlying: Common stock · 2,816 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:21 UTC |
Ho MaykinDirector
|
GrantStock options (right to buy) · Derivative | 15,768 | $0.00 Strike: $35.50 | $0.00 |
DisclosureSEC source: 0001439222-25-000053 · wk-form4_1750710074.xml · derivative · entry 3 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,768 Underlying: Common stock · 15,768 shares Expires 2035-06-18 F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:21 UTC |
Ho MaykinDirector
|
GrantRestricted stock units · Derivative | 2,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000053 · wk-form4_1750710074.xml · derivative · entry 2 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,816 Underlying: Common stock · 2,816 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:17 UTC |
Smith CynthiaDirector
|
GrantStock options (right to buy) · Derivative | 15,768 | $0.00 Strike: $35.50 | $0.00 |
DisclosureSEC source: 0001439222-25-000047 · wk-form4_1750709855.xml · derivative · entry 3 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,768 Underlying: Common stock · 15,768 shares Expires 2035-06-18 F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:17 UTC |
Smith CynthiaDirector
|
GrantRestricted stock units · Derivative | 2,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000047 · wk-form4_1750709855.xml · derivative · entry 2 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,816 Underlying: Common stock · 2,816 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:18 UTC |
Scadden DavidDirector
|
GrantStock options (right to buy) · Derivative | 15,768 | $0.00 Strike: $35.50 | $0.00 |
DisclosureSEC source: 0001439222-25-000049 · wk-form4_1750709929.xml · derivative · entry 3 Scadden David · CIK 0001707715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,768 Underlying: Common stock · 15,768 shares Expires 2035-06-18 F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:18 UTC |
Scadden DavidDirector
|
GrantRestricted stock units · Derivative | 2,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000049 · wk-form4_1750709929.xml · derivative · entry 2 Scadden David · CIK 0001707715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,816 Underlying: Common stock · 2,816 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:15 UTC |
Owen Adams CatherineDirector
|
Exercise / conversionRestricted stock units · Derivative | 1,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000043 · wk-form4_1750191300.xml · derivative · entry 2 Owen Adams Catherine · CIK 0001816838 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,976 Underlying: Common stock · 1,977 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:15 UTC |
Owen Adams CatherineDirector
|
Exercise / conversionCommon stock | 1,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000043 · wk-form4_1750191300.xml · nonDerivative · entry 1 Owen Adams Catherine · CIK 0001816838 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:16 UTC |
CAPELLO JEFFREY DDirector
|
Exercise / conversionRestricted stock units · Derivative | 1,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000045 · wk-form4_1750191390.xml · derivative · entry 2 CAPELLO JEFFREY D · CIK 0001224108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,976 Underlying: Common stock · 1,977 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:16 UTC |
CAPELLO JEFFREY DDirector
|
Exercise / conversionCommon stock | 1,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000045 · wk-form4_1750191390.xml · nonDerivative · entry 1 CAPELLO JEFFREY D · CIK 0001224108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2025 Filed Apr 10, 2025 20:02 UTC |
FOUSE JACQUALYN ADirector
|
SaleCommon stock | 7,497 | $25.90 | $194,172.30 |
DisclosureSEC source: 0001439222-25-000029 · wk-form4_1744315371.xml · nonDerivative · entry 2 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,220 F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated April 8, 2022. Read SEC document |
| April 08, 2025 Filed Apr 10, 2025 20:02 UTC |
FOUSE JACQUALYN ADirector
|
Exercise / conversionRestricted stock units · Derivative | 15,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000029 · wk-form4_1744315371.xml · derivative · entry 3 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 15,933 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. F3 · derivative.expiration_date: The restricted stock units were granted on April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| April 08, 2025 Filed Apr 10, 2025 20:02 UTC |
FOUSE JACQUALYN ADirector
|
Exercise / conversionCommon stock | 15,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000029 · wk-form4_1744315371.xml · nonDerivative · entry 1 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:18 UTC |
Viswanadhan KrishnanChief Corp Dev & Strategy
|
GrantStock options (right to buy) · Derivative | 55,374 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001439222-25-000027 · wk-form4_1741382325.xml · derivative · entry 2 Viswanadhan Krishnan · CIK 0001999913 · Chief Corp Dev & Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,374 Underlying: Common stock · 55,374 shares Expires 2035-03-05 F3 · derivative.exercise_date: This option was granted on March 5, 2025. The shares underlying this option vest as to 25% of the underlying shares on March 5, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:18 UTC |
Viswanadhan KrishnanChief Corp Dev & Strategy
|
GrantRestricted stock units · Derivative | 24,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000027 · wk-form4_1741382325.xml · derivative · entry 1 Viswanadhan Krishnan · CIK 0001999913 · Chief Corp Dev & Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,300 Underlying: Common stock · 24,300 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on March 5, 2025. Beginning on March 5, 2026, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on March 5, 2025. Beginning on March 5, 2026, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:12 UTC |
Milanova TsvetaChief Commercial Officer
|
SaleCommon stock | 1,681 | $35.54 | $59,742.74 |
DisclosureSEC source: 0001439222-25-000017 · wk-form4_1741122771.xml · nonDerivative · entry 2 Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,892 F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:08 UTC |
Gheuens SarahChief Medical Officer
|
SaleCommon stock | 1,681 | $35.54 | $59,742.74 |
DisclosureSEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · nonDerivative · entry 6 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,897 F4 · kind: hares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:08 UTC |
Gheuens SarahChief Medical Officer
|
SaleCommon stock | 1,187 | $35.54 | $42,185.98 |
DisclosureSEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · nonDerivative · entry 4 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,911 F3 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:08 UTC |
Gheuens SarahChief Medical Officer
|
SaleCommon stock | 1,137 | $35.54 | $40,408.98 |
DisclosureSEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · nonDerivative · entry 2 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,098 F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2022. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:17 UTC |
Burns James WilliamChief Legal Officer
|
SaleCommon stock | 1,681 | $35.54 | $59,742.74 |
DisclosureSEC source: 0001439222-25-000021 · wk-form4_1741123013.xml · nonDerivative · entry 6 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,449 F4 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:17 UTC |
Burns James WilliamChief Legal Officer
|
SaleCommon stock | 1,187 | $35.54 | $42,185.98 |
DisclosureSEC source: 0001439222-25-000021 · wk-form4_1741123013.xml · nonDerivative · entry 4 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,463 F3 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:17 UTC |
Burns James WilliamChief Legal Officer
|
SaleCommon stock | 1,137 | $35.54 | $40,408.98 |
DisclosureSEC source: 0001439222-25-000021 · wk-form4_1741123013.xml · nonDerivative · entry 2 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,650 F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2022. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:15 UTC |
Jones CeciliaChief Financial Officer
|
SaleCommon stock | 1,681 | $35.54 | $59,742.74 |
DisclosureSEC source: 0001439222-25-000019 · wk-form4_1741122903.xml · nonDerivative · entry 4 Jones Cecilia · CIK 0001840056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,829 F3 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:15 UTC |
Jones CeciliaChief Financial Officer
|
SaleCommon stock | 594 | $35.54 | $21,110.76 |
DisclosureSEC source: 0001439222-25-000019 · wk-form4_1741122903.xml · nonDerivative · entry 2 Jones Cecilia · CIK 0001840056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,843 F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:10 UTC |
Goff BrianDirector · Chief Executive Officer
|
SaleCommon stock | 8,794 | $35.54 | $312,538.76 |
DisclosureSEC source: 0001439222-25-000015 · wk-form4_1741122616.xml · nonDerivative · entry 4 Goff Brian · CIK 0001546216 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,345 F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:10 UTC |
Goff BrianDirector · Chief Executive Officer
|
SaleCommon stock | 4,153 | $35.54 | $147,597.62 |
DisclosureSEC source: 0001439222-25-000015 · wk-form4_1741122616.xml · nonDerivative · entry 2 Goff Brian · CIK 0001546216 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,139 F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:06 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
Exercise / conversionRestricted stock units · Derivative | 2,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000011 · wk-form4_1741122407.xml · derivative · entry 11 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,900 Underlying: Common stock · 2,450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F10 · derivative.exercise_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments. F10 · derivative.expiration_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:06 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
SaleCommon stock | 727 | $35.54 | $25,837.58 |
DisclosureSEC source: 0001439222-25-000011 · wk-form4_1741122407.xml · nonDerivative · entry 6 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,414 F4 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:06 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
SaleCommon stock | 697 | $35.54 | $24,771.38 |
DisclosureSEC source: 0001439222-25-000011 · wk-form4_1741122407.xml · nonDerivative · entry 4 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,691 F3 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:06 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
SaleCommon stock | 231 | $35.54 | $8,209.74 |
DisclosureSEC source: 0001439222-25-000011 · wk-form4_1741122407.xml · nonDerivative · entry 2 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,038 F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2022. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:12 UTC |
Milanova TsvetaChief Commercial Officer
|
Exercise / conversionRestricted stock units · Derivative | 5,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000017 · wk-form4_1741122771.xml · derivative · entry 5 Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,333 Underlying: Common stock · 5,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments. F5 · derivative.expiration_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:12 UTC |
Milanova TsvetaChief Commercial Officer
|
GrantStock options (right to buy) · Derivative | 43,500 | $0.00 Strike: $35.54 | $0.00 |
DisclosureSEC source: 0001439222-25-000017 · wk-form4_1741122771.xml · derivative · entry 4 Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,500 Underlying: Common stock · 43,500 shares Expires 2035-03-01 F4 · derivative.exercise_date: This option was granted on March 1, 2025. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:12 UTC |
Milanova TsvetaChief Commercial Officer
|
GrantRestricted stock units · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000017 · wk-form4_1741122771.xml · derivative · entry 3 Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,000 Underlying: Common stock · 12,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments. F3 · derivative.expiration_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:12 UTC |
Milanova TsvetaChief Commercial Officer
|
Exercise / conversionCommon stock | 5,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000017 · wk-form4_1741122771.xml · nonDerivative · entry 1 Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:08 UTC |
Gheuens SarahChief Medical Officer
|
Exercise / conversionRestricted stock units · Derivative | 5,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · derivative · entry 11 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,333 Underlying: Common stock · 5,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F10 · derivative.exercise_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments. F10 · derivative.expiration_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:08 UTC |
Gheuens SarahChief Medical Officer
|
Exercise / conversionRestricted stock units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · derivative · entry 10 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,000 Underlying: Common stock · 4,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F9 · derivative.exercise_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. F9 · derivative.expiration_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:08 UTC |
Gheuens SarahChief Medical Officer
|
Exercise / conversionRestricted stock units · Derivative | 3,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · derivative · entry 9 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 3,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F8 · derivative.exercise_date: The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. F8 · derivative.expiration_date: The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:08 UTC |
Gheuens SarahChief Medical Officer
|
GrantStock options (right to buy) · Derivative | 43,500 | $0.00 Strike: $35.54 | $0.00 |
DisclosureSEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · derivative · entry 8 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,500 Underlying: Common stock · 43,500 shares Expires 2035-03-01 F7 · derivative.exercise_date: This option was granted on March 1, 2025. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:08 UTC |
Gheuens SarahChief Medical Officer
|
GrantRestricted stock units · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · derivative · entry 7 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,000 Underlying: Common stock · 12,000 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F6 · derivative.exercise_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments. F6 · derivative.expiration_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.